To include your compound in the COVID-19 Resource Center, submit it here.

Ceplene: Phase II

A Data Saftey Monitoring Board (DSMB) said that after reviewing 12 weeks of treatment data

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE